An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...

From revolutionary CRISPR treatment to heavy drinking dangers, here's what you need to know about the latest health research.

A CRISPR-based gene therapy showed improvement in lipids in difficult-to-treat patients, but one study raised flags after a ...

Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.

The cholesterol medication alirocumab, a PCSK9 inhibitor, combined with a statin appeared to reduce LDL cholesterol levels by ...

The medication, which significantly lowers the risk of heart attacks, could be a promising alternative to expensive and ...

In a small, short duration trial (12 weeks), a new medication called DR10624 reduced triglyceride levels in most patients ...

In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL ...

LDL levels were reduced substantially among heart transplant recipients assigned alirocumab. NEW ORLEANS — In the CAVIAR ...

Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an ...

A cholesterol-lowering regimen that combines PCSK9 inhibitor alirocumab with statin therapy safely reduced low-density ...